Clinical Trial: A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)

U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07705607) titled 'A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)' on July 10.

Brief Summary: Researchers are looking for new ways to treat diabetic macular edema (DME). In this trial, researchers want to learn if a trial medicine called MK-8748 can treat DME. An available standard (usual) treatment for DME is aflibercept. However, standard treatments such as aflibercept may not work for every person.

The main goal of this trial is to learn if MK-8748 works as well as aflibercept to treat DME.

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: Diabetic Retinopathy Macula...